vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $22.7M, roughly 1.1× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -22.7%, a 23.5% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -19.2%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 29.8%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

EDIT vs RFIL — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.1× larger
EDIT
$24.7M
$22.7M
RFIL
Growing faster (revenue YoY)
RFIL
RFIL
+42.1% gap
RFIL
22.9%
-19.2%
EDIT
Higher net margin
RFIL
RFIL
23.5% more per $
RFIL
0.8%
-22.7%
EDIT
More free cash flow
RFIL
RFIL
$38.5M more FCF
RFIL
$2.0M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
29.8%
RFIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDIT
EDIT
RFIL
RFIL
Revenue
$24.7M
$22.7M
Net Profit
$-5.6M
$173.0K
Gross Margin
36.8%
Operating Margin
-31.3%
4.0%
Net Margin
-22.7%
0.8%
Revenue YoY
-19.2%
22.9%
Net Profit YoY
87.6%
172.7%
EPS (diluted)
$0.03
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
RFIL
RFIL
Q4 25
$24.7M
$22.7M
Q3 25
$7.5M
$19.8M
Q2 25
$3.6M
$18.9M
Q1 25
$4.7M
$19.2M
Q4 24
$30.6M
$18.5M
Q3 24
$61.0K
$16.8M
Q2 24
$513.0K
$16.1M
Q1 24
$1.1M
$13.5M
Net Profit
EDIT
EDIT
RFIL
RFIL
Q4 25
$-5.6M
$173.0K
Q3 25
$-25.1M
$392.0K
Q2 25
$-53.2M
$-245.0K
Q1 25
$-76.1M
$-245.0K
Q4 24
$-45.4M
$-238.0K
Q3 24
$-62.1M
$-705.0K
Q2 24
$-67.6M
$-4.3M
Q1 24
$-62.0M
$-1.4M
Gross Margin
EDIT
EDIT
RFIL
RFIL
Q4 25
36.8%
Q3 25
34.0%
Q2 25
31.5%
Q1 25
29.8%
Q4 24
31.3%
Q3 24
29.5%
Q2 24
29.9%
Q1 24
24.5%
Operating Margin
EDIT
EDIT
RFIL
RFIL
Q4 25
-31.3%
4.0%
Q3 25
-325.4%
3.6%
Q2 25
-1440.6%
0.6%
Q1 25
-1635.1%
0.3%
Q4 24
-152.2%
0.5%
Q3 24
-107649.2%
-2.5%
Q2 24
-14016.2%
-2.6%
Q1 24
-5902.3%
-15.5%
Net Margin
EDIT
EDIT
RFIL
RFIL
Q4 25
-22.7%
0.8%
Q3 25
-333.0%
2.0%
Q2 25
-1487.8%
-1.3%
Q1 25
-1633.5%
-1.3%
Q4 24
-148.3%
-1.3%
Q3 24
-101870.5%
-4.2%
Q2 24
-13178.8%
-26.7%
Q1 24
-5458.1%
-10.1%
EPS (diluted)
EDIT
EDIT
RFIL
RFIL
Q4 25
$0.03
$0.01
Q3 25
$-0.28
$0.04
Q2 25
$-0.63
$-0.02
Q1 25
$-0.92
$-0.02
Q4 24
$-0.55
$-0.02
Q3 24
$-0.75
$-0.07
Q2 24
$-0.82
$-0.41
Q1 24
$-0.76
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
RFIL
RFIL
Cash + ST InvestmentsLiquidity on hand
$146.6M
$5.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
$35.2M
Total Assets
$186.5M
$73.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
RFIL
RFIL
Q4 25
$146.6M
$5.1M
Q3 25
$165.6M
$3.0M
Q2 25
$178.5M
$3.6M
Q1 25
$221.0M
$1.3M
Q4 24
$269.9M
$839.0K
Q3 24
$265.1M
$1.8M
Q2 24
$279.1M
$1.4M
Q1 24
$296.2M
$4.5M
Total Debt
EDIT
EDIT
RFIL
RFIL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
RFIL
RFIL
Q4 25
$27.3M
$35.2M
Q3 25
$13.5M
$34.8M
Q2 25
$19.2M
$34.2M
Q1 25
$62.4M
$34.2M
Q4 24
$134.3M
$34.1M
Q3 24
$175.6M
$34.1M
Q2 24
$232.0M
$34.6M
Q1 24
$294.4M
$38.7M
Total Assets
EDIT
EDIT
RFIL
RFIL
Q4 25
$186.5M
$73.0M
Q3 25
$201.8M
$73.2M
Q2 25
$210.6M
$72.7M
Q1 25
$263.7M
$70.4M
Q4 24
$341.6M
$71.0M
Q3 24
$327.6M
$71.9M
Q2 24
$384.8M
$72.8M
Q1 24
$440.3M
$79.1M
Debt / Equity
EDIT
EDIT
RFIL
RFIL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
RFIL
RFIL
Operating Cash FlowLast quarter
$-36.4M
$2.1M
Free Cash FlowOCF − Capex
$-36.4M
$2.0M
FCF MarginFCF / Revenue
-147.3%
9.0%
Capex IntensityCapex / Revenue
0.2%
0.3%
Cash ConversionOCF / Net Profit
12.13×
TTM Free Cash FlowTrailing 4 quarters
$4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
RFIL
RFIL
Q4 25
$-36.4M
$2.1M
Q3 25
$-30.8M
$-311.0K
Q2 25
$-50.2M
$2.2M
Q1 25
$-47.8M
$601.0K
Q4 24
$-50.8M
$-244.0K
Q3 24
$-52.6M
$2.4M
Q2 24
$-57.1M
$197.0K
Q1 24
$-49.9M
$840.0K
Free Cash Flow
EDIT
EDIT
RFIL
RFIL
Q4 25
$-36.4M
$2.0M
Q3 25
$-31.3M
$-419.0K
Q2 25
$2.2M
Q1 25
$-47.9M
$574.0K
Q4 24
$-51.3M
$-418.0K
Q3 24
$-55.5M
$2.1M
Q2 24
$-60.6M
$28.0K
Q1 24
$-51.7M
$697.0K
FCF Margin
EDIT
EDIT
RFIL
RFIL
Q4 25
-147.3%
9.0%
Q3 25
-414.6%
-2.1%
Q2 25
11.4%
Q1 25
-1028.6%
3.0%
Q4 24
-167.6%
-2.3%
Q3 24
-90998.4%
12.6%
Q2 24
-11804.3%
0.2%
Q1 24
-4558.9%
5.2%
Capex Intensity
EDIT
EDIT
RFIL
RFIL
Q4 25
0.2%
0.3%
Q3 25
5.7%
0.5%
Q2 25
0.0%
0.2%
Q1 25
2.4%
0.1%
Q4 24
1.8%
0.9%
Q3 24
4788.5%
1.5%
Q2 24
681.1%
1.0%
Q1 24
164.8%
1.1%
Cash Conversion
EDIT
EDIT
RFIL
RFIL
Q4 25
12.13×
Q3 25
-0.79×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

RFIL
RFIL

US$20.9M92%
Non Us$1.8M8%

Related Comparisons